BioCardia Inc (BCDA)
2.135
+0.14
(+7.29%)
USD |
NASDAQ |
Nov 21, 16:00
2.18
+0.04
(+2.11%)
Pre-Market: 08:21
BioCardia Max Drawdown (5Y): 98.91% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 98.91% |
| September 30, 2024 | 98.91% |
| August 31, 2024 | 98.91% |
| July 31, 2024 | 98.91% |
| June 30, 2024 | 98.89% |
| May 31, 2024 | 98.66% |
| April 30, 2024 | 98.66% |
| March 31, 2024 | 98.66% |
| February 29, 2024 | 98.66% |
| January 31, 2024 | 98.66% |
| December 31, 2023 | 98.66% |
| November 30, 2023 | 98.66% |
| October 31, 2023 | 98.66% |
| September 30, 2023 | 98.66% |
| August 31, 2023 | 98.66% |
| July 31, 2023 | 98.66% |
| June 30, 2023 | 98.66% |
| May 31, 2023 | 98.66% |
| April 30, 2023 | 98.66% |
| March 31, 2023 | 98.66% |
| February 28, 2023 | 98.66% |
| January 31, 2023 | 98.66% |
| December 31, 2022 | 98.66% |
| November 30, 2022 | 98.66% |
| October 31, 2022 | 98.66% |
| Date | Value |
|---|---|
| September 30, 2022 | 98.66% |
| August 31, 2022 | 98.66% |
| July 31, 2022 | 98.66% |
| June 30, 2022 | 98.66% |
| May 31, 2022 | 98.66% |
| April 30, 2022 | 98.66% |
| March 31, 2022 | 98.66% |
| February 28, 2022 | 98.66% |
| January 31, 2022 | 98.66% |
| December 31, 2021 | 98.66% |
| November 30, 2021 | 98.49% |
| October 31, 2021 | 98.49% |
| September 30, 2021 | 98.49% |
| August 31, 2021 | 98.49% |
| July 31, 2021 | 98.49% |
| June 30, 2021 | 98.49% |
| May 31, 2021 | 98.49% |
| April 30, 2021 | 98.49% |
| March 31, 2021 | 98.49% |
| February 28, 2021 | 98.49% |
| January 31, 2021 | 98.49% |
| December 31, 2020 | 98.49% |
| November 30, 2020 | 98.49% |
| October 31, 2020 | 98.44% |
| September 30, 2020 | 98.39% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
97.49%
Minimum
Nov 2019
98.91%
Maximum
Jul 2024
98.52%
Average
98.66%
Median
Dec 2021
Max Drawdown (5Y) Benchmarks
| Alnylam Pharmaceuticals Inc | 42.46% |
| The Cooper Companies Inc | 45.45% |
| Theriva Biologics Inc | 99.81% |
| Zevra Therapeutics Inc | 99.27% |
| Instil Bio Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -67.22 |
| Beta (5Y) | 1.276 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 91.76% |
| Historical Sharpe Ratio (5Y) | -0.5531 |
| Historical Sortino (5Y) | -0.9716 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 42.97% |